Bank of New York Mellon’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.7K | Sell |
2,663
-11,185
| -81% | -$82.8K | ﹤0.01% | 4092 |
|
|
2025
Q1 | $119K | Hold |
13,848
| – | – | ﹤0.01% | 3961 |
|
|
2024
Q4 | $495K | Sell |
13,848
-1,039
| -7% | -$37.1K | ﹤0.01% | 3513 |
|
|
2024
Q3 | $703K | Sell |
14,887
-3,226
| -18% | -$152K | ﹤0.01% | 3323 |
|
|
2024
Q2 | $910K | Buy |
18,113
+2,964
| +20% | +$149K | ﹤0.01% | 3253 |
|
|
2024
Q1 | $1.7M | Sell |
15,149
-317
| -2% | -$35.5K | ﹤0.01% | 2853 |
|
|
2023
Q4 | $897K | Buy |
15,466
+436
| +3% | +$25.3K | ﹤0.01% | 3240 |
|
|
2023
Q3 | $477K | Sell |
15,030
-37
| -0.2% | -$1.18K | ﹤0.01% | 3566 |
|
|
2023
Q2 | $1.24M | Buy |
15,067
+276
| +2% | +$22.7K | ﹤0.01% | 3077 |
|
|
2023
Q1 | $1.52M | Buy |
14,791
+70
| +0.5% | +$7.19K | ﹤0.01% | 2944 |
|
|
2022
Q4 | $2.16M | Buy |
14,721
+297
| +2% | +$43.5K | ﹤0.01% | 2821 |
|
|
2022
Q3 | $2.44M | Buy |
14,424
+676
| +5% | +$114K | ﹤0.01% | 2716 |
|
|
2022
Q2 | $1.59M | Buy |
13,748
+2,424
| +21% | +$280K | ﹤0.01% | 2959 |
|
|
2022
Q1 | $1.13M | Buy |
11,324
+127
| +1% | +$12.7K | ﹤0.01% | 3235 |
|
|
2021
Q4 | $1.74M | Buy |
11,197
+365
| +3% | +$56.8K | ﹤0.01% | 3074 |
|
|
2021
Q3 | $2.55M | Buy |
10,832
+872
| +9% | +$206K | ﹤0.01% | 2845 |
|
|
2021
Q2 | $3.38M | Sell |
9,960
-500
| -5% | -$170K | ﹤0.01% | 2677 |
|
|
2021
Q1 | $4.23M | Sell |
10,460
-599
| -5% | -$242K | ﹤0.01% | 2516 |
|
|
2020
Q4 | $7.36M | Sell |
11,059
-76
| -0.7% | -$50.6K | ﹤0.01% | 2165 |
|
|
2020
Q3 | $5.18M | Buy |
11,135
+281
| +3% | +$131K | ﹤0.01% | 2199 |
|
|
2020
Q2 | $6.35M | Buy |
10,854
+3,053
| +39% | +$1.79M | ﹤0.01% | 2090 |
|
|
2020
Q1 | $1.14M | Buy |
7,801
+31
| +0.4% | +$4.52K | ﹤0.01% | 2881 |
|
|
2019
Q4 | $1.11M | Buy |
7,770
+3,726
| +92% | +$534K | ﹤0.01% | 3185 |
|
|
2019
Q3 | $160K | Sell |
4,044
-244
| -6% | -$9.65K | ﹤0.01% | 3936 |
|
|
2019
Q2 | $434K | Buy |
4,288
+2,738
| +177% | +$277K | ﹤0.01% | 3666 |
|
|
2019
Q1 | $204K | Sell |
1,550
-18
| -1% | -$2.37K | ﹤0.01% | 3875 |
|
|
2018
Q4 | $160K | Buy |
1,568
+252
| +19% | +$25.7K | ﹤0.01% | 3888 |
|
|
2018
Q3 | $329K | Buy |
1,316
+51
| +4% | +$12.8K | ﹤0.01% | 3788 |
|
|
2018
Q2 | $564K | Buy |
1,265
+273
| +28% | +$122K | ﹤0.01% | 3576 |
|
|
2018
Q1 | $392K | Buy |
992
+375
| +61% | +$148K | ﹤0.01% | 3681 |
|
|
2017
Q4 | $254K | Buy |
617
+83
| +16% | +$34.2K | ﹤0.01% | 3851 |
|
|
2017
Q3 | $231K | Buy |
+534
| New | +$231K | ﹤0.01% | 3828 |
|